MPTP-induced mouse model of Parkinson’s disease: a promising direction for therapeutic strategies

MPTP-induced mouse model of Parkinson’s disease: a promising direction for therapeutic strategies

Among the popular animal models of Parkinson’s disease (PD) commonly used in research are those that employ neurotoxins, especially 1-methyl- 4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). This neurotoxin exerts it neurotoxicity by causing a barrage of insults, such as oxidative stress, mitochondria...

Full description

Bibliographic Details
Main Authors:	Mustapha, Musa, Mat Taib, Che Norma
Format:	Article
Published:	Association of Basic Medical Sciences of FBIH 2021

Similar Items

MPTP- induced Balb/c mice recapitulate compensatory Parkinson’s-like motor features
by: Mustapha, Musa, et al.
Published: (2024)

Beneficial role of vitexin in Parkinsons disease
by: Mustapha, Musa, et al.
Published: (2023)

Integrating nutriepigenomics in Parkinson's disease management: new promising strategy in the omics era
by: Razali, Khairiah, et al.
Published: (2022)

Effects of stress on a mouse model of parkinson's disease.
by: Nurul Dini Abdul Rahim.
Published: (2012)

Neurobehavioral and biochemical features of a mouse model for Parkinson’s disease.
by: Lee, Elianna Shu Hui.
Published: (2012)

Investigating the effect of stress on a mouse model for Parkinson’s disease
by: Yeo, Natalie
Published: (2017)

Behavioural and biochemical abnormalities in a mouse model for Parkinson's disease.
by: Ten, Rachel Rui Xian.
Published: (2013)

Mitochondrial dysfunction and Parkinson’s disease — near-infrared photobiomodulation as a potential therapeutic strategy
by: Foo, Aaron Song Chuan, et al.
Published: (2021)

Development of novel agonists for the orphan nuclear receptor, Nurr1 : a therapeutic strategy for Parkinson’s disease
by: Toh, Hui Ting
Published: (2019)

Roles and mechanisms of renalase in cardiovascular disease: a promising therapeutic target
by: Li, Yue, et al.
Published: (2020)

Human alkaloid biosynthesis : chemical inducers of Parkinson's disease?
by: Hatzios, Stavroula K. (Stavroula-Artemis K.)
Published: (2007)

Therapeutic Potential Of Menstrual Blood-Derived Endometrium Stem Cells On In Vitro And In Vivo Parkinson's Disease Models
by: Li, Han
Published: (2019)

Modeling Parkinson’s disease in yeast
by: Neo, Natalie Ling Yin
Published: (2020)

Modeling progression of Parkinson's disease
by: Ji, Christina X.(Christina Xinyue)
Published: (2020)

Neuro-therapeutic benefits of Centella asiatica on some neurodegenerative diseases: a review
by: Chiroma, Samaila Musa, et al.
Published: (2017)

A systems biology approach towards the identification of candidate therapeutic genes and potential biomarkers for Parkinson’s disease
by: Sakharkar, Meena Kishore, et al.
Published: (2019)

Impaired neurogenesis in the hippocampus of an adult VPS35 mutant mouse model of Parkinson's disease through interaction with APP
by: Jiang, Mei, et al.
Published: (2022)

Ultrasound Enhanced Delivery of Molecular Imaging and Therapeutic Agents in Alzheimer's Disease Mouse Models
by: Treat, Lisa H., et al.
Published: (2010)

Gait analysis in Parkinson's disease
by: Soon, Qing Rong
Published: (2022)

Genetic susceptibility of Parkinson's disease.
by: Yeo, Thomas Jian Hong.
Published: (2012)

Deep Phenotyping of Parkinson’s Disease
by: Dorsey, E. Ray, et al.
Published: (2021)

Parkinson’s Disease - A review on treatment strategies and its advances
by: Subashini, Raman, et al.
Published: (2020)

Voice characteristics of people with Parkinsons disease (PwP): An overview on baseline vocal characteristics and guidelines for therapeutic singing
by: Ang, Mei Foong
Published: (2018)

Effect of stress on neuroinflammation in the substantia nigra and striatum of LRRK2 (R1441G) mouse model for Parkinson’s disease
by: Chen, Jiayi
Published: (2015)

Biosynthesis and medicinal chemistry of therapeutically promising plant natural products
by: Chau, Yasmin-Pei(Yasmin-Pei Kamal)
Published: (2019)

Evaluating somatic mosaicism In Parkinson's disease
by: Heng, Yue Jing
Published: (2024)

Defining the causes of sporadic Parkinson's disease in the global Parkinson's genetics program (GP2)
by: Towns, Clodagh, et al.
Published: (2024)

Neuroimmunomodulatory Properties of DPSCs in an In Vitro Model of Parkinson's Disease
by: Gnanasegaran, N., et al.
Published: (2017)

Association of HLA locus variant in Parkinson's disease
by: Zhao, Y., et al.
Published: (2012)

Identification of genetic modifiers of Parkinson's disease in yeast
by: Pui, Carmen Sze Min
Published: (2023)

Identification of genetic modifiers of Parkinson’s disease in yeast
by: Yap, Ernest Gim Seng
Published: (2023)

Identifying genes in Parkinson’s disease : state of the art
by: Chew, Elaine Guo Yan, et al.
Published: (2020)

Predicting parkinson's disease using gait analysis
by: Fwu, Joey Hui Ning
Published: (2014)

Polyamine pathway contributes to the pathogenesis of Parkinson disease
by: Lewandowski, Nicole M., et al.
Published: (2014)

Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors
by: Soldner, Frank, et al.
Published: (2015)

Microbiome and Metabolome Insights into the Role of the Gastrointestinal–Brain Axis in Parkinson’s and Alzheimer’s Disease: Unveiling Potential Therapeutic Targets
by: Zacharias, Helena U., et al.
Published: (2022)

Impact of single amino acid substitutions in Parkinsonism-associated deglycase-PARK7 and their association with Parkinson’s disease
by: Farah Anjum, et al.
Published: (2022)

Impact of Single Amino Acid Substitutions in Parkinsonism Associated Deglycase-PARK7 and Their Association with Parkinson’s Disease
by: Farah Anjum, et al.
Published: (2022)

Characterizing the modulation of mGluR5 in a 6-OHDA-induced rat model of Parkinson's disease
by: Lamb, Peter (Peter Alexander John)
Published: (2009)

Comparison of game development framework and model for parkinson disease rehabilitation
by: Abd Rauf, Muhammad Fairuz, et al.
Published: (2023)